Retrospective analysis of glioblastoma multiforme (GBM) patients treated initially with BCNU compared to temozolomide (TMZ) with concomitant radiation therapy

被引：0
|
作者：
Vinjamuri, M. [1 ]
Adumala, R. [1 ]
Altaha, R. [1 ]
Hobbs, J. [1 ]
Crowell, E. [1 ]
机构：
[1] West Virginia Univ, Morgantown, WV USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2071
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Concurrent radiochemotherapy plus adjuvant chemotherapy (CT) with temozolomide (TMZ) after surgery of glioblastoma multiforme (GBM) in patients out of a trial:: A retrospective analysis
    Nadal, E.
    Gil, M.
    Maldonado, X.
    Verger, E.
    Fuentes, R.
    González, S.
    Balaña, C.
    Rodríguez, J.
    Gallego, O.
    Navarro, V.
    NEURO-ONCOLOGY, 2006, 8 (04) : 349 - 349
  • [12] Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
    McGirt, Matthew J.
    Than, Khoi D.
    Weingart, Jon D.
    Chaichana, Kaisorn L.
    Attenello, Frank J.
    Olivi, Alessandro
    Laterra, John
    Kleinberg, Lawrence R.
    Grossman, Stuart A.
    Brem, Henry
    Quinones-Hinojosa, Alfredo
    JOURNAL OF NEUROSURGERY, 2009, 110 (03) : 583 - 588
  • [13] Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients
    Vinjamuri, Mridula
    Adumala, Rakesh R.
    Altaha, Ramin
    Hobbs, Gerald R.
    Crowell, Edward B., Jr.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (02) : 221 - 225
  • [14] Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients
    Mridula Vinjamuri
    Rakesh R. Adumala
    Ramin Altaha
    Gerald R. Hobbs
    Edward B. Crowell
    Journal of Neuro-Oncology, 2009, 91 : 221 - 225
  • [15] LONG-TERM SURVIVAL OF A PEDIATRIC PATIENT WITH GLIOBLASTOMA MULTIFORME (GBM) FOLLOWING MULTIPLE TREATMENTS WITH CARMUSTINE (BCNU) WAFERS AND TEMOZOLOMIDE (TMZ)
    Ollero, A.
    Marquez-Rivas, J.
    Ramirez, G.
    Quiroga, E.
    Gimenez-Pando, J.
    Segovia-Vergel, C.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1084 - 1085
  • [16] PHASE II AND PHARMACOGENOMICS (PGX) STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, Nicholas A.
    Lamborn, Kathleen L.
    Polley, Mei-Yin C.
    Hsieh, Emily
    Kivett, Valerie
    Page, Margaretta S.
    Parvataneni, Rupa
    Nicol, Steve
    Thornton, Don
    Prados, Michael
    NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621
  • [17] A phase I study of temozolomide (TMZ) and RAD001 in patients (pts) with glioblastoma multiforme (GBM)
    Mason, W. P.
    MacNeil, M.
    Easaw, J.
    McIntosh, L.
    Lwin, Z.
    Chen, E.
    Eisenhauer, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [18] PHASE I/II STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (XRT) IN PATIENTS (PTS) WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, N.
    Lamborn, K.
    Chang, S.
    Page, M.
    Parvataneni, R.
    Chang, S.
    Liepa, A. M.
    Nicol, S.
    Thornton, D.
    Prados, M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1073 - 1074
  • [19] Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
    Stupp, R
    Dietrich, PY
    Kraljevic, SO
    Pica, A
    Maillard, I
    Maeder, P
    Meuli, R
    Janzer, R
    Pizzolato, G
    Miralbell, R
    Porchet, F
    Regli, L
    de Tribolet, N
    Mirimanoff, RO
    Leyvraz, S
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1375 - 1382
  • [20] Erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): results from a randomized phase II trial (EORTC 26034)
    van den Bent, M. J.
    Brandes, A. A.
    Rampling, R.
    Kouwenhoven, M.
    Kros, J.
    Carpentier, A.
    Clement, P.
    Klughammer, B.
    Lacombe, D.
    Gorlia, T.
    EJC SUPPLEMENTS, 2007, 5 (04): : 228 - 228
12345